| |
| |
|
| Insider
Information: |
Luo Mary Z. |
| Relationship: |
COO,Chief Scientist & ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,433,554 |
|
|
Indirect Shares
|
8,057,435 |
|
|
| Direct
Value |
$100,043,405 |
|
|
|
Indirect Value
|
$331,241,153 |
|
|
| Total
Shares |
10,490,989 |
|
|
| Total
Value |
$431,284,558 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-17 |
4 |
D |
$43.05 |
$303,589 |
I/I |
(7,052) |
1,229,756 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-17 |
4 |
D |
$43.05 |
$678,812 |
D/D |
(15,768) |
2,433,554 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-15 |
4 |
OE |
$12.46 |
$8,996,693 |
D/D |
722,046 |
2,858,043 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-15 |
4 |
D |
$43.05 |
$17,595,439 |
D/D |
(408,721) |
2,449,322 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-15 |
4 |
OE |
$12.46 |
$3,874,188 |
I/I |
310,930 |
1,439,466 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-15 |
4 |
D |
$43.05 |
$8,724,427 |
I/I |
(202,658) |
1,236,808 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2024-03-06 |
4 |
D |
$46.31 |
$138,467 |
I/I |
(2,990) |
1,128,536 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2024-03-06 |
4 |
D |
$46.31 |
$325,606 |
D/D |
(7,031) |
2,135,997 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
27,110 |
1,131,526 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
64,310 |
2,143,028 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-17 |
4 |
D |
$36.29 |
$255,917 |
I/I |
(7,052) |
1,455,602 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-17 |
4 |
D |
$36.29 |
$572,221 |
D/D |
(15,768) |
2,078,718 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
D |
$37.60 |
$375,925 |
I/I |
(9,998) |
1,462,654 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
D |
$37.60 |
$949,062 |
D/D |
(25,241) |
2,094,486 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
114,730 |
0 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Sci. and Chairman |
• • • |
2023-03-15 |
4 |
D |
$36.84 |
$310,709 |
D/D |
(8,434) |
2,177,092 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Sci. and Chairman |
• • • |
2023-03-15 |
4 |
D |
$36.84 |
$103,263 |
I/I |
(2,803) |
1,530,017 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
34,301 |
1,532,820 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
81,383 |
2,185,526 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-20 |
4 |
AS |
$34.21 |
$364,365 |
D/D |
(10,650) |
2,104,143 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-19 |
4 |
AS |
$33.76 |
$1,408,761 |
D/D |
(41,730) |
2,114,793 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-18 |
4 |
AS |
$33.97 |
$2,289,101 |
D/D |
(67,046) |
2,156,523 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-17 |
4 |
AS |
$35.74 |
$1,801,440 |
D/D |
(50,376) |
2,223,569 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-16 |
4 |
AS |
$35.58 |
$2,433,457 |
D/D |
(68,069) |
2,273,945 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-17 |
4 |
D |
$34.18 |
$241,037 |
I/I |
(7,052) |
1,498,519 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
